Max Robotics — Global Service Robot Directory + US Certification

About

Marieke T. de Boer is a leading surgical researcher whose work centers on advancing minimally invasive techniques in hepatopancreatobiliary surgery, with a particular focus on cost-effectiveness, quality of life, and nationwide implementation outcomes. Her most impactful contribution is the LEOPARD trial (55 citations), a landmark randomized study comparing minimally invasive and open distal pancreatectomy that established the cost-effectiveness and quality-of-life benefits of the minimally invasive approach. Dr. de Boer has been instrumental in shaping the adoption of robotic surgery in the Netherlands, leading nationwide analyses on robotic liver surgery implementation (41 citations) and demonstrating its safety and feasibility during the learning curve. Her propensity-matched comparison of robotic versus laparoscopic liver resection (12 citations) provides critical evidence for surgical decision-making, while her investigation into conversion risk factors (8 citations) offers practical guidance for optimizing patient selection and intraoperative management. Through these high-impact studies, Dr. de Boer has not only advanced the evidence base for minimally invasive surgery but also provided actionable insights for surgeons transitioning to robotic platforms, ultimately improving patient outcomes and recovery.